Pharmaceutical

UK point-of-care production of cell therapies could arrive in 2025

The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Nov 23, 2024 - 06:00
UK point-of-care production of cell therapies could arrive in 2025
The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
Read the original article

Tags:

Previous Article

Incyte’s $750M Acquisition Shaken by Key Trial Pause and Asset Cuts

Next Article

J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Signal: Illumina under investigation by SEC over $8bn Grail acquisition

Signal: Illumina under investigation by SEC over $8bn G...

Aug 16, 2023

Robert F. Kennedy is pitching centrism on health care, even on abortion

Robert F. Kennedy is pitching centrism on health care, ...

Oct 10, 2023

STAT+: ‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders

STAT+: ‘We don’t agree’ on drug pricing policy, FDA chi...

Jun 8, 2023